Interaction of Platelets and Anidulafungin against Aspergillus fumigatus

ABSTRACT The combination of platelets and anidulafungin at 0.03 μg/ml significantly (P < 0.05) reduced the germination rate and hyphal elongation in Aspergillus fumigatus compared to those with either anidulafungin only or an untreated control. Platelets decreased the expression of the fks gene, which plays an important role in cell wall synthesis. Our results suggest that human platelets plus anidulafungin might contribute to defense against A. fumigatus.

[1]  P. Aronowitz,et al.  Invasive Aspergillosis , 2013, Journal of General Internal Medicine.

[2]  C. Lass‐Flörl,et al.  Platelets enhance activity of antimycotic substances against non-Aspergillus fumigatus Aspergillus species in vitro. , 2011, Medical mycology.

[3]  D. Greco,et al.  Synergy of Caspofungin with Human Polymorphonuclear Granulocytes for Killing Candida albicans , 2010, Antimicrobial Agents and Chemotherapy.

[4]  M. Dierich,et al.  Potential synergistic activity of antimycotic substances in combination with human platelets against Aspergillus fumigatus. , 2010, The Journal of antimicrobial chemotherapy.

[5]  M. Dierich,et al.  Potential antifungal effects of human platelets against zygomycetes in vitro. , 2009, The Journal of infectious diseases.

[6]  M. Dierich,et al.  Human platelets attenuate Aspergillus species via granule-dependent mechanisms. , 2008, The Journal of infectious diseases.

[7]  C. Lass‐Flörl,et al.  In vitro susceptibility‐testing in Aspergillus species , 2008, Mycoses.

[8]  M. Arendrup,et al.  Establishing In Vitro-In Vivo Correlations for Aspergillus fumigatus: the Challenge of Azoles versus Echinocandins , 2008, Antimicrobial Agents and Chemotherapy.

[9]  Russell E. Lewis,et al.  Caspofungin-mediated beta-glucan unmasking and enhancement of human polymorphonuclear neutrophil activity against Aspergillus and non-Aspergillus hyphae. , 2008, The Journal of infectious diseases.

[10]  W. Burgstaller,et al.  Interaction of 5-hydroxytryptamine (serotonin) against Aspergillus spp. in vitro. , 2007, International journal of antimicrobial agents.

[11]  Timothy J. Foster,et al.  The interaction of bacterial pathogens with platelets , 2006, Nature Reviews Microbiology.

[12]  T. Walsh,et al.  Effects of Lipid Formulations of Amphotericin B on Activity of Human Monocytes against Aspergillus fumigatus , 2006, Antimicrobial Agents and Chemotherapy.

[13]  K. Jurk,et al.  Platelets: Physiology and Biochemistry , 2005, Seminars in thrombosis and hemostasis.

[14]  E. Brummer,et al.  Combined action of micafungin, a new echinocandin, and human phagocytes for antifungal activity against Aspergillus fumigatus. , 2004, Microbes and infection.

[15]  D. Denning.  Echinocandin antifungal drugs , 2003, The Lancet.

[16]  M. Selsted,et al.  Antimicrobial Peptides from Human Platelets , 2002, Infection and Immunity.

[17]  T. Walsh,et al.  Antifungal Triazoles and Polymorphonuclear Leukocytes Synergize To Cause Increased Hyphal Damage to Scedosporium prolificans and Scedosporium apiospermum , 2002, Antimicrobial Agents and Chemotherapy.

[18]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[19]  E. Brummer,et al.  Collaboration of human phagocytes with LY 303366 for antifungal activity against Aspergillus fumigatus. , 1999, The Journal of antimicrobial chemotherapy.

[20]  T. Meshulam,et al.  Human Platelets Damage Aspergillus fumigatus Hyphae and May Supplement Killing by Neutrophils , 1998, Infection and Immunity.

[21]  M. Yeaman.  The role of platelets in antimicrobial host defense. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[22]  B. Klein,et al.  Virulence Factors of Medically Important Fungi , 1996 .

[23]  Thomas D. Schmittgen,et al.  Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2 2 DD C T Method , 2022 .